Cancer Epigenetics

 

 

 

<p style="&quot;text-align:" justify;"=""> The study of epigenetic modifications to the genome of cancer cells that do not include a change in the nucleotide sequence is known as Cancer Epigenetics. Epigenetic alterations are as important as genetic mutations in a cell's transformation to cancer and their manipulation embraces the great potential for cancer prevention, detection, and therapy. A variety of compounds are considered as epigenetic carcinogens such as Usenet, diethylstilbestrol, Hexachlorobenzene and nickel compounds. They result in an increased incidence of tumors, but they do not show mutagen activity.

    Related Conference of Cancer Epigenetics

    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 16-17, 2024

    9th World Conference on Breast and Cervical Cancer

    London, UK
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France
    November 24-25, 2024

    7th International Conference on Anti-Cancer Drugs

    Vancouver, Canada

    Cancer Epigenetics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in